• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Numinus Launches New Clinic Licensing Platform

Microdose NewsDesk by Microdose NewsDesk
April 11, 2023
in Industry
Reading Time: 5 mins read
A A
Numinus Launches New Clinic Licensing Platform

It’s been a tough time for patients in need of psychedelic therapy. First, the Biden administration announced the ending of Covid emergency measures around telemedicine. Then we’ve had a run of clinic closings, with both KWC and Field Trip Health announcing closings.

Patients have been suffering from lack of access (see our interview with an Army veteran who had treatments abruptly ended when his clinic suddenly closed).

Which is why today’s news from Numinus might be good news for patients.

Numinus has launched a new clinic licensing model, Numinus Network, offering independent practitioners the opportunity to own and operate their own clinic under the Numinus Wellness brand.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

This model could provide practitioners with an alternate model, allowing them to retain ownership of their practice while leveraging Numinus patient protocols. They’ve also announced a partnership with Healing Commercial Real Estate Inc., to help provide Numinus Network licensees with turn-key locations (see our interview with the Healing Real Estate team here).

Continue on your trip...

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

See the full press release below.

 

 

Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion

 

  • Licensing model enables Numinus to scale with limited capital investment and overhead
  • Provides practitioners with an alternate model, allowing them to retain ownership of their practice and performance while leveraging Numinus patient protocols
  • New partnership with Healing Commercial Real Estate Inc. provides Numinus Network licensees with turn-key locations

VANCOUVER, BC, April 11, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has launched a new clinic licensing model, named the Numinus Network, offering independent practitioners the opportunity to own and operate their own clinic under the trusted Numinus Wellness brand through a licensing and services arrangement. As a leader in the mental health care space, Numinus has earned a reputation for delivering a high-quality model of care to its clients. With the launch of this new licensing model, Numinus seeks to expand access and bring its expertise to new regions across North America with reduced capital investment.

“We believe that we are on the verge of a significant shift in mental health care as psychedelic-assisted therapy is becoming more accessible, and Numinus wants to take a leading role in providing this important clinical care. The Numinus Network will allow us to work with practitioners who believe in the Numinus brand and protocols, but prefer greater independence in leading their team and practice,” said Payton Nyquvest, Founder and CEO. “Through our Numinus Network partnership, we can work together to advocate for and support people in more communities who are suffering and would like to try a new approach to treatment.”

As a Numinus Network partner, practitioners will be able to benefit from a proven clinic model, comprehensive training curriculum, access to Numinus treatment protocols, ongoing operational and marketing support, and a trusted brand. They will also have access to Numinus’ extensive network of highly experienced health care professionals.

In addition, Numinus is pleased to facilitate a turn-key clinic solution to licensees, through a new partnership with Healing Commercial Real Estate Inc. (“Healing CREI”) – a health care focused real estate investment company with deep market knowledge of the psychedelic sector. Through this agreement, Numinus Network licensees will have the option of leasing a fully functioning Numinus Wellness clinic location – including leasehold improvements and clinic infrastructure, directly from Healing CREI.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

“We’re excited to partner with Numinus as they launch this new growth initiative, and look forward to supporting further clinic expansion,” said Cody Shandraw

Order Genuine Lasix Now

, Founder and President of Healing CREI. “This partnership presents an opportunity for Numinus to further solidify its position as one of the industry leaders prepared to meet the growing demand for psychedelic-assisted therapy services. Leveraging market data, we can help build clinic infrastructure using a targeted planning process to determine key regions where the psychedelic, behavioral health, and wellness industry is currently lacking or underserved. Through this process, we are uniquely positioned to help new Numinus Network licensees find and establish the best possible locations for their new businesses.”

Clinic investment costs and licensing fees will vary depending on the particular licensing arrangement, location, regional exclusivity terms and other business factors. Numinus is currently in discussion with several prospective clinic owners.

Numinus will continue to evaluate corporately-owned clinic growth opportunities alongside the Numinus Network launch. Practitioners who are interested in working with Numinus at one of Company’s 12 corporately-owned clinics are invited to reach out to Numinus’ People and Culture team at: peopleandculture@numinus.com.

About Numinus

Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.

About Healing CREI

Healing CREI owns and invests in real estate supporting the healthcare industry across the United States and Canada, including psychedelic therapy centers, behavioral health facilities, as well as therapy and rehabilitation services, positioning the company to become one of the top healthcare investment companies. Healing CREI’s commitment to providing high-quality care and extensive industry knowledge uniquely positions the company for success in the competitive healthcare real estate market.

Learn more at: https://healing.realestate/

Tags: Numinus Wellness
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Encyclopedia Psychedelica: What is LSD?

Encyclopedia Psychedelica: What is LSD?

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.